{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T13:00:00Z","timestamp":1791464400733,"version":"4.3.4"},"reference-count":56,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T00:00:00Z","timestamp":1658448000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Chronic histiocytic intervillositis (CHI) is a rare placental lesion with a high recurrence rate and poor perinatal outcomes. There are currently limited guidelines regarding the diagnosis of this condition in the index pregnancy and treatment where recurrence is suspected.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The primary objective of this systematic review and meta-analysis was to determine the perinatal outcomes of pregnancies affected by chronic histiocytic intervillositis and to what extent they can be improved with treatment. The secondary objective was to assess the relationship between CHI lesion severity and pregnancy loss.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A systematic search of Ovid Embase, Web of Science, Science Direct, PubMed, Ovid Medline, Google Scholar and CINAHL was carried out. Case reports, cohort, case-control and randomised controlled trials (RCT) detailing the perinatal outcomes of CHI pregnancies, both treated and untreated, were included.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>No RCTs were identified. However, in a review population of 659 pregnancies, with additional 7 in case reports, CHI treatments included aspirin, prednisone, prednisolone, low molecular weight heparin (LMWH), hydroxychloroquine and adalimumab. A descriptive synthesis of data found mixed results for treatments in relation to live birth, miscarriage and fetal growth restriction outcomes. Furthermore, quantitative synthesis of 38 pregnancies revealed a non-significant improvement in live birth rate with CHI targeted treatment (OR 1.79 [95% CI 0.33-9.61] (p=0.50), while meta-analysis of CHI severity in line with pregnancy loss, in a sample of 231 pregnancies, revealed lower odds of pregnancy loss with less severe lesions (OR: 0.17 [0.03-0.80], p=0.03).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This systematic review and meta-analysis reinforce notions surrounding the insufficient evidence for CHI treatment. It also strengthens previous hypotheses detailing the positive association between CHI lesion severity and odds of pregnancy loss. Aspirin, LMWH, prednisolone, hydroxychloroquine and adalimumab are candidates with varying levels of weak to moderate evidence supporting their use. Further prospective research is required to obtain robust evidence pertaining to treatment safety and efficacy and optimal drug regimes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic Review Registration<\/jats:title>\n                    <jats:p>[website], identifier CRD42021237604<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2022.945543","type":"journal-article","created":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T06:32:56Z","timestamp":1658471576000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":33,"title":["Chronic histiocytic intervillositis (CHI): current treatments and perinatal outcomes, a systematic review and a meta-analysis"],"prefix":"10.3389","volume":"13","author":[{"given":"Laurel","family":"Moar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chloe","family":"Simela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surabhi","family":"Nanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Marnerides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mudher","family":"Al-Adnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Nelson-Piercy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kypros H.","family":"Nicolaides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panicos","family":"Shangaris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,7,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0046-8177(00)80009-X","article-title":"Chronic histiocytic intervillositis: A placental lesion associated with recurrent reproductive loss","volume":"31","author":"Boyd","year":"2000","journal-title":"Hum Pathol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e13373","DOI":"10.1111\/aji.13373","article-title":"Chronic histiocytic intervillositis: A breakdown in immune tolerance comparable to allograft rejection","volume":"85","author":"Brady","year":"2021","journal-title":"Am J Reprod Immunol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/j.1600-0897.1987.tb00162.x","article-title":"Fibrinoid and trophoblastic necrosis with massive chronic intervillositis: An extreme variant of villitis of unknown etiology","volume":"15","author":"Labarrere","year":"1987","journal-title":"Am J Reprod Immunol Microbiol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.placenta.2017.11.012","article-title":"Towards standardized criteria for diagnosing chronic intervillositis of unknown etiology: A systematic review","volume":"61","author":"Bos","year":"2018","journal-title":"Placenta"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/S0368-2315(06)76468-7","article-title":"Pronostic p\u00e9rinatal des grossesses compliqu\u00e9es d\u2019intervillites chroniques placentaires","volume":"35","author":"Rota","year":"2006","journal-title":"J Gyn\u00e9cologie Obs Biol la Reprod"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2019.07.1144","article-title":"Chronic intervillositis of unknown etiology (CIUE): a cause for reproductive failure","volume":"112","author":"Simula","year":"2019","journal-title":"Fertil Steril"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1177\/1093526619882522","article-title":"Reproducibility of grading in chronic intervillositis of unknown etiology","volume":"23","author":"Ongaro","year":"2020","journal-title":"Pediatr Dev Pathol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2021-241637","article-title":"Chronic histiocytic intervillositis (CHI): an under-recognised condition with potential serious sequelae in pregnancy","volume":"14","author":"Lee","year":"2021","journal-title":"BMJ Case Rep"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/0046-8177(95)90201-5","article-title":"Massive chronic intervillositis associated with recurrent abortions","volume":"26","author":"Doss","year":"1995","journal-title":"Hum Pathol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-994176","article-title":"Placental pathology and antiphospholipid antibodies: A descriptive study","volume":"14","author":"Salafia","year":"1997","journal-title":"Am J Perinatol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/aji.12125","article-title":"An immunological basis for chronic histiocytic intervillositis in recurrent fetal loss","volume":"70","author":"Reus","year":"2013","journal-title":"Am J Reprod Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.placenta.2014.02.006","article-title":"Intercellular adhesion molecule-1 expression in massive chronic intervillositis: Implications for the invasion of maternal cells into fetal tissues","volume":"35","author":"Labarrere","year":"2014","journal-title":"Placenta"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.2350\/14-12-1582-OA.1","article-title":"Significance of C4d immunostaining in placental chronic intervillositis","volume":"18","author":"Bendon","year":"2015","journal-title":"Pediatr Dev Pathol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"12611","DOI":"10.1038\/s41598-020-69191-9","article-title":"Adverse perinatal outcomes of chronic intervillositis of unknown etiology: an observational retrospective study of 122 cases","volume":"10","author":"Mattuizzi","year":"2020","journal-title":"Sci Rep"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000001549","article-title":"Chronic intervillositis of unknown etiology","volume":"44","author":"Sauvestre","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s13669-013-0041-z","article-title":"Intrauterine growth restriction (IUGR): Etiology and diagnosis","volume":"2","author":"Suhag","year":"2013","journal-title":"Curr Obstet Gynecol Rep"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp22X718829","article-title":"MBRRACE 2021: preventing maternal deaths \u2014 we are all part of the solution","volume":"72","author":"MacGregor","year":"2022","journal-title":"Br J Gen Pract"},{"key":"B18","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ejogrb.2008.06.012","article-title":"Chronic intervillositis of unknown etiology (CIUE): Relation between placental lesions and perinatal outcome","volume":"143","author":"Parant","year":"2009","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.placenta.2010.11.021","article-title":"Chronic histiocytic intervillositis of unknown etiology: Clinical features in a consecutive series of 69 cases","volume":"32","author":"Marchaudon","year":"2011","journal-title":"Placenta"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.13105\/wjma.v5.i4.80","article-title":"Assessing the quality of studies in meta-analyses: Advantages and limitations of the Newcastle Ottawa scale","volume":"5","author":"Luchini","year":"2017","journal-title":"World J Meta Analysis"},{"key":"B21","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1177\/2632084320947559","article-title":"Optimising the value of the critical appraisal skills programme (CASP) tool for quality appraisal in qualitative evidence synthesis","volume":"1","author":"Long","year":"2020","journal-title":"Res Methods Med Heal Sci"},{"key":"B22","unstructured":"LefebvreC\n            Glanville JBS\n          Cochrane handbook for systematic reviews of interventions version 6.2. cochrane; 20212021"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.5455\/2320-1770.ijrcog20141258","article-title":"Chronic histiocytic intervillositis- a rare placental cause of poor obstetric outcome: a clinicopathological study and literature review","volume":"3","author":"Ramya","year":"2014","journal-title":"Int J Reprod Contraception Obstet Gynecol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3109\/08916934.2014.939267","article-title":"Chronic histiocytic intervillositis: Outcome, associated diseases and treatment in a multicenter prospective study","volume":"48","author":"Mekinian","year":"2015","journal-title":"Autoimmunity"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.37856","article-title":"Recurrent chronic histiocytic intervillositis with intrauterine growth restriction, osteopenia, and fractures","volume":"170","author":"Crawford","year":"2016","journal-title":"Am J Med Genet Part A"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.placenta.2016.04.017","article-title":"Perinatal prognosis of pregnancies complicated by placental chronic villitis or intervillositis of unknown etiology and combined lesions: About a series of 178 cases","volume":"44","author":"Nowak","year":"2016","journal-title":"Placenta"},{"key":"B28","doi-asserted-by":"publisher","first-page":"26","DOI":"10.17140\/GOROJ-3-133","article-title":"A series of rare chronic histiocytic intervillositis cases and its association with fetal growth restriction","volume":"3","author":"Sabra","year":"2016","journal-title":"Gynecol Obstet Res - Open J"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1111\/jog.13404","article-title":"Chronic histiocytic intervillositis in three consecutive pregnancies in a single patient: Differing clinical results and pathology according to treatment used","volume":"43","author":"Ozawa","year":"2017","journal-title":"J Obstet Gynaecol Res"},{"key":"B30","doi-asserted-by":"publisher","first-page":"bcr2016217886","DOI":"10.1136\/bcr-2016-217886","article-title":"Successful pregnancy following treatment of recurrent chronic histiocytic intervillositis","author":"Vardi","year":"2017","journal-title":"BMJ Case Rep"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.placenta.2018.02.002","article-title":"Chronic histiocytic intervillositis - clinical, biochemical and radiological findings: An observational study","volume":"64","author":"Koby","year":"2018","journal-title":"Placenta"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2019.02.036","article-title":"Antagonists of TNFalpha for recurrent miscarriages: 2 illustrative cases","volume":"236","author":"Mekinian","year":"2019","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1177\/1093526620957843","article-title":"Diffuse subamniotic calcification: A novel pattern of placental calcification","volume":"23","author":"Nohr","year":"2020","journal-title":"Pediatr Dev Pathol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.326.7387.475","article-title":"Research pointers: Survey of claims of no effect in abstracts of cochrane reviews","volume":"326","author":"Alderson","year":"2003","journal-title":"BMJ"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.revmed.2017.10.422","article-title":"Intervillites chroniques histiocytaires : bilan et prise en charge","volume":"39","author":"Mekinian","year":"2018","journal-title":"La Rev M\u00e9decine Interne"},{"key":"B36","doi-asserted-by":"publisher","first-page":"698","DOI":"10.5858\/arpa.2015-0225-CC","article-title":"Sampling and definitions of placental lesions: Amsterdam placental workshop group consensus statement","volume":"140","author":"Khong","year":"2016","journal-title":"Arch Pathol Lab Med"},{"key":"B37","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.placenta.2020.01.001","article-title":"Clinical outcomes in chronic intervillositis of unknown etiology","volume":"91","author":"Bos","year":"2020","journal-title":"Placenta"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.placenta.2019.12.020","article-title":"Is chronic histiocytic intervillositis a severe placental disease? a case-control study","volume":"91","author":"Homatter","year":"2020","journal-title":"Placenta"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.placenta.2020.07.032","article-title":"Chronic intervillositis of unknown etiology (CIUE): Prevalence, patterns and reproductive outcomes at a tertiary referral institution","volume":"100","author":"Simula","year":"2020","journal-title":"Placenta"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.placenta.2010.09.012","article-title":"Pathological characteristics of a series of rare chronic histiocytic intervillositis of the placenta","volume":"31","author":"Traeder","year":"2010","journal-title":"Placenta"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.placenta.2010.10.005","article-title":"Chronic intervillositis of the placenta: A systematic review","volume":"31","author":"Contro","year":"2010","journal-title":"Placenta"},{"key":"B42","first-page":"1","article-title":"The investigation and treatment of couples with recurrent first-trimester and second-trimester miscarriage","volume-title":"RCOG green-top guidel no 17","year":"2011"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2007.05.046","article-title":"Maternal corticosteroid use and orofacial clefts","volume":"197","author":"Carmichael","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1002\/bdra.23248","article-title":"Corticosteroid use and risk of orofacial clefts","volume":"100","author":"Skuladottir","year":"2014","journal-title":"Birth Defects Res Part A Clin Mol Teratol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002859.pub2","article-title":"Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant","volume":"2012","author":"Empson","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/hropen\/hoy004","article-title":"ESHRE guideline: recurrent pregnancy loss","volume":"2018","author":"Bender Atik","year":"2018","journal-title":"Hum Reprod Open"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1056\/nejm199707173370302","article-title":"Prednisone and aspirin in women with autoantibodies and unexplained recurrent fetal loss","volume":"337","author":"Laskin","year":"1997","journal-title":"N Engl J Med"},{"key":"B48","unstructured":"BelardoCAA\n          Summary of suggested treatments for chronic histiocytic intervillositis (CHI)2019"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012852.pub2","article-title":"Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss","volume":"2020","author":"Hamuly\u00e1k","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare10010168","article-title":"The potential benefit of hydroxychloroquine in chronic placental inflammation of unknown etiology associated with adverse pregnancy outcomes","volume":"10","author":"Bouariu","year":"2022","journal-title":"Healthcare"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000267203.55718.aa","article-title":"Prevention of recurrent fetal growth restriction","volume":"110","author":"Berghella","year":"2007","journal-title":"Obstet Gynecol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.753220","article-title":"Immunomodulatory therapy reduces the severity of placental lesions in chronic histiocytic intervillositis","volume":"8","author":"Brady","year":"2021","journal-title":"Front Med"},{"key":"B53","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/s0368-2315%2806%2976411-0","article-title":"Combining corticosteroid and aspirin for the prevention of recurrent villitis or intervillositis of unknown etiology","volume":"35","author":"Boog","year":"2006","journal-title":"J Gynecol Obstet Biol la Reprod"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.825075","article-title":"Chronic inflammatory placental disorders associated with recurrent adverse pregnancy outcome","volume":"13","author":"Cornish","year":"2022","journal-title":"Front Immunol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1002\/uog.19112","article-title":"Screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks\u2019 gestation","volume":"52","author":"Tan","year":"2018","journal-title":"Ultrasound Obstet Gynecol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2020.07.020","article-title":"First trimester preeclampsia screening and prediction","author":"Chaemsaithong","year":"2020","journal-title":"Am J Obstet Gynecol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.945543\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T06:33:00Z","timestamp":1658471580000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.945543\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,22]]},"references-count":56,"alternative-id":["10.3389\/fendo.2022.945543"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2022.945543","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,22]]},"article-number":"945543"}}